Axiogenesis, Metrion Biosciences Collaborate

News   Nov 08, 2016

 
Axiogenesis, Metrion Biosciences Collaborate
 
 
 

RELATED ARTICLES

Diabetes Drug Could Be Re-purposed to Help End Transplant Rejection

News

A diabetes drug currently undergoing development could be repurposed to help end transplant rejection, without the side-effects of current immunosuppressive drugs.

READ MORE

Long-Term Negative Physical and Mental Health Effects Associated With Disordered Eating

News

Findings from large twin study show disordered eating among 24-year-old women and men was an indicator of higher body weight, larger waist circumference, and lower psychological well-being ten years later.

READ MORE

Study Shows Cancer Patients Are Choosing Less Severe Side Effects Over Treatment Efficacy

News

When choosing their preferred treatment, people with chronic lymphocytic leukemia (CLL) place the highest value on medicines that deliver the longest progression-free survival, but are willing to swap some drug efficacy for a reduced risk of serious adverse events according to a new study.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE